Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
IEEE Journal of Biomedical and Health Informatics|February 25, 2020
Construction of Empirical Care Pathways Process Models From Multiple Real-World DatasetsJuan Gonzalez-Garcia, Carlos Telleria-Orriols, Francisco Estupinan-Romero, et al.
Journal of the International AIDS Society|November 15, 2014
Efficacy of a dual therapy based on darunavir/ritonavir and etravirine in ART-experienced patientsJose Ignacio Bernardino, Francisco Xavier Zamora, Eulalia Valencia, et al.
The American Journal of Tropical Medicine and Hygiene|February 16, 2021
Model Prediction for In-Hospital Mortality in Patients with COVID-19: A Case-Control Study in Isfahan, IranIbrahim Abdollahpour, Isabel Aguilar-Palacio, Juan Gonzalez-Garcia, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 17, 2014
Shorter telomere length predicts poorer immunological recovery in virologically suppressed HIV-1-infected patients treated with combined antiretroviral therapyJosé-Ramón Blanco, Inma Jarrin, Alfredo Martinez, et al.
HIV Clinical Trials|August 26, 2010
Impact of baseline antiretroviral resistance status on efficacy outcomes among patients receiving maraviroc plus optimized background therapy in the MOTIVATE 1 and 2 trialsMark Nelson, Martin Fisher, Juan Gonzalez-Garcia, et al.
Acta Obstetricia Et Gynecologica Scandinavica|May 9, 2007
Obstetric and perinatal complications in HIV-infected women. Analysis of a cohort of 167 pregnancies between 1997 and 2003Covadonga Martí, Jose M Peña, Isabel Bates, et al.
Medicine|September 22, 2018
Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patientsJulian Alexander Portocarrero Nuñez, Juan Gonzalez-Garcia, Juan Berenguer, et al.
Plos One|April 1, 2015
Prediction of week 4 virological response in hepatitis C for making decision on triple therapy: the Optim studyManuel Romero-Gómez, Juan Turnes, Javier Ampuero, et al.
AIDS and Behavior|June 15, 2025
Preparing for the Next Physician's Visit: Usability and Validity of a Mobile Health App for People Living with HIVJoanna Cano-Smith, Ana Delgado-Hierro, Luis Ramos-Ruperto, et al.
Lancet (London, England)|July 29, 2017
Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trialDavid A Margolis, Juan Gonzalez-Garcia, Hans-Jürgen Stellbrink, et al.
Pageof 2